Skip to main content
  • About
  • Careers
  • Locations
ArentFox Schiff

Main navigation

  • Attorneys
  • Industries & Practices
  • Insights
Search the Site Search the Site
Toggle Main Menu

Main navigation

  • Attorneys
  • Industries & Practices
  • Insights
    • Blogs
    • Alerts
    • Events
    • News
    • The Fine Print
    • Fashion Counsel
    • Press Releases
    • Health Care Counsel Blog
    • Managing Automotive Blog
    • AI Law Blog
    • Customs & Import Compliance Blog
    • Longevity Lens
    • Trade Secrets Case Watch
    • Trump’s Policy Playbook
    • Consumer Products Watch
    • Environmental Law Advisor
    • Energy & Cleantech Counsel
    • The In-House Advisor
    • International Arbitration & Dispute Resolution Blog
    • Investigations Blog
    • National Security Counsel
    • Privacy Counsel

Footer

  • About
    • Leadership
    • Alumni
    • Diversity
    • Pro Bono
  • Careers
    • Attorney Opportunities
    • Professional Opportunities
    • Summer Program
  • Locations
    • Washington, DC
    • Chicago
    • New York
    • Los Angeles
    • Boston
    • San Francisco
    • Lake Forest
    • Ann Arbor
    • Decentraland
  • Contact
    • Client Payments
    • Subscribe

Search

Breadcrumb

  1. Services

Insights on

8746 total results. Page 7 of 350.

Alerts
It’s H-1B Lottery Time, But With Big Changes for Employers This Year
February 3, 2026
Berin S. Romagnolo, Nancy A. Noonan

H-1B work visas are the most common work visas for foreign nationals in professional positions (which are jobs requiring at least a bachelor’s degree in a specific specialty). Most employers can only apply for a worker’s initial H-1B one time per year.

Events
2026 NASDA Winter Policy Conference
February 3, 2026
Karen Ellis Carr

FDA Practice Leader and Agriculture & AgTech Industry Leader Karen Carr will present to the Plant Agriculture & Pesticide Regulations policy committee at the 2026 National Association of State Departments of Agriculture (NASDA) Winter Policy Conference on February 3, 2026.

Health Care Counsel Blog
OIG Issues Special Advisory Bulletin on DTC Prescription Drug Sales to Federal Health Care Program Enrollees
February 2, 2026
Douglas A. Grimm, Stephanie Trunk

On January 27, the US Department of Health and Human Services Office of Inspector General (OIG) issued a Special Advisory Bulletin providing significant guidance for pharmaceutical manufacturers offering prescription drugs through direct-to-consumer (DTC) programs to patients enrolled in federal health care programs.

Alerts
‘Be Prepared to Defend It’ – FTC Signals More Aggressive Posture Toward Noncompete Agreements
February 2, 2026
Brian D. Schneider, Sean A. Worley, Nicole Curtis Martinez, Meredith Gillespie

The Federal Trade Commission (FTC) held a workshop on January 27, entitled, “Moving Forward: Protecting Workers from Anticompetitive Noncompete Agreements.”

Investigations Blog
DOJ Criminal Division’s Fraud Section 2025 Year in Review Touts Record Takedown, More Corporate Cases, and an Expanded Mission
February 2, 2026
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Shoshana Golden, Meredith Gillespie

Headlines that Matter for Companies and Executives in Regulated Industries

Press Release
ArentFox Schiff Names Aram Ordubegian as Los Angeles Office Managing Partner
February 2, 2026

ArentFox Schiff is pleased to announce that Aram Ordubegian has been named managing partner of the firm’s Los Angeles office. He succeeds Aaron Jacoby, who will continue in his active practice and role as chair of ArentFox Schiff’s Automotive & Transportation industry group. Both attorneys also sit on the firm’s Executive Committee.

Events
Trump Accounts (IRC §530A): Estate, Tax, and Wealth Planning Considerations
February 1, 2026
Susan T. Bart

AFS Partner and ACTEC Fellow Susan Bart, presented on the estate, tax, and wealth planning implications of newly enacted Trump Accounts during ACTEC’s Trust and Estate Talk podcast.

Alerts
FDA Issues Report on PFAS in Cosmetics: Key Findings, Risks, and Regulatory Implications
January 30, 2026
Robert G. Edwards, Ph.D., Karen Ellis Carr, Katia Asche, Lynn R. Fiorentino

Per- and polyfluoroalkyl substances (PFAS) are used as intentionally added ingredients in some cosmetic formulations, primarily on account of their water- and oil-resistance and long-lasting properties, for conditioning and smoothing the skin and hair, or for modifying product consistency and texture.

Press Release
2026 Opus Prize
January 29, 2026

AFS counsel James Fahy has been selected to serve as a juror for the 2026 Opus Prize in collaboration with DePaul University.

Press Release
Top Organizations Encourage Appeals Court to Keep Protections in Place for Migrant Children
January 29, 2026

On behalf of a coalition of the nation’s leading organizations dedicated to the care, health, education, well-being, and welfare of children and families, ArentFox Schiff, filed an amicus brief in the US Court of Appeals for the Ninth Circuit in support of the plaintiffs.

Alerts
EEOC Votes to Revoke 2024 Enforcement Guidance on Harassment in the Workplace
January 29, 2026
Alexandra M. Romero, Nicholas L. Collins

On January 22, in a 2-1 vote, the US Equal Employment Opportunity Commission (EEOC) rescinded its 2024 Enforcement Guidance on Harassment in the Workplace, including portions addressing gender identity and LGBTQ+ issues.

Alerts
New Draft Guidance Addresses FDA’s Records Access Authority for Cosmetics Under MoCRA
January 29, 2026
Shoshana Golden, Emily M. Cowley

On January 21, the US Food and Drug Administration (FDA) issued a draft guidance clarifying the agency’s authority to access and copy records related to cosmetic products under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). Cosmetic companies should take care to ensure that their recordkeeping policies and procedures comply with these requirements.

Press Release
ArentFox Schiff Bolsters Alcohol Beverage Regulatory Capabilities With Addition of Four-Person Team
January 29, 2026

ArentFox Schiff is pleased to announce the additions of Partner Nichole D. Shustack, Counsel Michael Rudy, Senior Associate Isabelle R. Cunningham, and Director Helen C. Plunkett to its Food, Drug, Medical Device & Cosmetic Practice with a focus on the alcohol beverage industry. Nichole and Helen join in Washington, DC, with Michael and Isabelle joining in Boston and New York, respectively. Nichole and Isabelle are both recognized in Chambers USA 2025 and join ArentFox Schiff from a Chambers‑ranked team.

Longevity Lens
Lupo and Hethcoat Quoted on ArentFox Schiff Launch of Longevity & Healthspan Industry Group
January 28, 2026
Anthony V. Lupo, Gayland O. Hethcoat II

ArentFox Schiff Chairman Anthony Lupo and Counsel Gayland Hethcoat were quoted on the firm’s newly launched Longevity & Healthspan Industry Group.

Longevity Lens
ArentFox Schiff Launches First-of-Its-Kind Longevity & Healthspan Industry Group
January 28, 2026

ArentFox Schiff is pleased to announce the launch of its Longevity & Healthspan Industry Group, a cross-sector initiative supporting the rapidly expanding ecosystem of companies advancing anti-aging innovation, wellness, and preventive health.

Alerts
A Rupture in the World Order, the End of a Pleasant Fiction, and the Beginning of a Harsh Reality
January 28, 2026
Birgit Matthiesen

On January 20, Canada’s Prime Minister Mark Carney addressed the World Economic Forum. Coming a week after his meeting with China’s President Xi Jinping, his remarks made headlines globally.

Alerts
The End of LIBOR: Hotel California Edition [Part VI]
January 28, 2026
Les Jacobowitz, Elizabeth Satarov, Andrew McArthur, Kimia Pourshadi

In an update earlier last year, we highlighted the ongoing legal developments in connection with key cases surrounding the London InterBank Offered Rate (LIBOR) manipulation scandal with respect to a pending United Kingdom (UK) Supreme Court hearing.

Energy & Cleantech Counsel
Illinois’ Data Center Boom: Incentives, Grid Pressures, and What to Watch
January 28, 2026
Amy Antoniolli, Jena Watson, Nick Kianpoor

Illinois’ data center market is booming because of strong state incentives, but that growth is tightening power supplies and raising reliability and cost concerns.

Events
Webinar: False Claims Act Enforcement Trends in the Health Care Industry
January 27, 2026
Hillary M. Stemple, Nadia Patel

False Claims Act Investigations Partners Hillary Stemple (Health Care) and Nadia Patel (Litigation) will host a Continuing Education webinar on recent trends in health care fraud enforcement for the Health Care Compliance Association on January 27, 2026.

Events
USMCA 2026 Review: Advancing North American Integration or Risking Shared Economic Decline
January 27, 2026
Angela M. Santos

International Trade & Investment Partner and Customs & Import Compliance Practice Leader Angela Santos will present on recent developments in international trade at ABA International Law Section’s The Americas Conference on January 27, 2026.

Fashion Counsel
Lupo Quoted on Tips for Brands After Saks Global Bankruptcy Filing
January 26, 2026
Anthony V. Lupo

ArentFox Schiff Chairman Anthony V. Lupo was quoted on the bankruptcy filing of the luxury retail conglomerate, Saks Global — owner of Saks Fifth Avenue, Saks Off 5th, Bergdorf Goodman, and Neiman Marcus — on what brands can recover capital and product during a Chapter 11 filing.

National Security Counsel
BIS Relaxes Drone Export Controls to Bolster Defense Industrial Base
January 26, 2026
Derek Ha, Kay C. Georgi, Megan Barnhill

In a January 20 interim final rule, the Bureau of Industry and Security (BIS) eased restrictions on the export, reexport, and transfer (in-country) of certain types of unmanned aerial vehicles (UAVs) to lower risk destinations.

Investigations Blog
DOJ False Claims Act Suit Targets Long Term Care Hospital Chain
January 26, 2026
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Shoshana Golden, Meredith Gillespie

Headlines that Matter for Companies and Executives in Regulated Industries

Customs & Import Compliance Blog
As the (Customs and Trade) World Turns: January 2026
January 23, 2026
Angela M. Santos, Antonio J. Rivera, Megan Barnhill, Nadia Patel, Jackson David Toof, Christopher H. Skinner, Kay C. Georgi, James Kim*, Jessica DiPietro, Sylvia G. Costelloe, Lucas A. Rock, Mario A. Torrico, Maya S. Cohen, Derek Ha, Natalie Tantisirirat, Collin M. Douglas, Terry M. Frederic, John M. Keblish, Tyler J. Kimberly, Andrew McArthur, Kendall K. Murphy, William G. Stroupe II

Welcome to the January 2026 issue of “As the (Customs and Trade) World Turns,” our monthly newsletter where we compile essential updates from the customs and trade world over the past month. We bring you the most recent and significant insights in an accessible format, concluding with our main takeaways — aka “And the Fox Says…” — on what you need to know.

Alerts
Model Behavior: FDA and EMA’s Guide to Good AI in Drug Development
January 23, 2026
Abha Kundi*, Emily M. Cowley

The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) just issued a joint statement outlining 10 “Guiding Principles” for using artificial intelligence (AI) in drug development.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Current page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • …
  • Next page Next ›
  • Last page Last »

Footer

  • About
    • Leadership
    • Alumni
    • Diversity
    • Pro Bono
  • Careers
    • Attorney Opportunities
    • Professional Opportunities
    • Summer Program
  • Locations
    • Washington, DC
    • Chicago
    • New York
    • Los Angeles
    • Boston
    • San Francisco
    • Lake Forest
    • Ann Arbor
    • Decentraland
  • Contact
    • Client Payments
    • Subscribe

Social

Linkedin Twitter Youtube

Sub footer

  • Disclaimer
  • Privacy Policy
  • Terms of Use
  • Accessibility
  • Non Discrimination

© Copyright 2026 ArentFox Schiff LLP. All Rights Reserved.

Back to Top